Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatobiliary malignancy.

B A Jones1, G J Gores

  • 1Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic, and Foundation, Rochester, Minnesota 55905, USA.

Clinics in Liver Disease
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetic resonance imaging findings in dogs with steroid-responsive meningitis-arteritis in the UK and their clinical significance: 53 cases (2013-2021).

The Journal of small animal practice·2024
Same author

Increasing Incidence of Intrahepatic Cholangiocarcinoma Relative to Hepatocellular Carcinoma in the United States.

Gastro hep advances·2024
Same author

Dealing with double trouble: Combination deworming against double-drug resistant cyathostomins.

International journal for parasitology. Drugs and drug resistance·2019
Same author

Origin of Perpendicular Magnetic Anisotropy and Large Orbital Moment in Fe Atoms on MgO.

Physical review letters·2015
Same author

Development and testing of a field diagnostic assay for peste des petits ruminants virus.

Transboundary and emerging diseases·2014
Same author

Reliability and validity of the psychiatry resident in-training examination.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Early detection of liver cancer in chronic cholestatic liver disease is crucial for liver transplantation. This review covers high-risk patient identification, diagnostic methods, and screening recommendations for better outcomes.

Area of Science:

  • Hepatology
  • Oncology
  • Transplantation

Background:

  • Chronic cholestatic liver diseases (e.g., primary biliary cirrhosis, primary sclerosing cholangitis) increase the risk of hepatobiliary malignancy.
  • Hepatocellular carcinoma and cholangiocarcinoma are serious complications requiring early detection.
  • Liver transplantation is the primary treatment for advanced stages of these conditions.

Purpose of the Study:

  • To review methods for identifying patients at high risk for hepatobiliary malignancy.
  • To discuss current diagnostic techniques for early cancer detection in cholestatic liver disease.
  • To provide recommendations for screening high-risk patient populations and review transplant outcomes.

Main Methods:

  • Literature review of diagnostic and screening strategies for hepatobiliary cancers in chronic liver disease.

Related Experiment Videos

  • Analysis of risk factors associated with hepatobiliary malignancy in cholestatic conditions.
  • Review of preliminary data on liver transplantation outcomes for cholangiocarcinoma post-radiation therapy.

    • Main Results:

    • Identification of key risk factors and patient groups requiring vigilant monitoring.
    • Evaluation of the efficacy of various diagnostic tools for early cancer detection.
    • Preliminary insights into the feasibility and outcomes of liver transplantation for cholangiocarcinoma.

    Conclusions:

    • Early diagnosis and screening are vital for managing hepatobiliary malignancy in chronic cholestatic liver disease.
    • Liver transplantation offers a potential treatment for advanced cases, with ongoing research into specific protocols like post-radiation therapy.
    • A proactive approach to screening high-risk patients can improve transplant candidacy and patient survival.